US Stock MarketDetailed Quotes

EYPT EyePoint Pharmaceuticals

Watchlist

7.130
-0.310-4.17%

Trading Dec 19 13:06 ET

486.63MMarket Cap-3.58P/E (TTM)

EyePoint Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

EyePoint Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 6.775M	--
--	2024/Q4	-- / 10.494M	--
--	2024/Q3	10.524M / 10.358M	--
--	2024/Q2	9.477M / 10.635M	--
--	2024/Q1	11.684M / 9.135M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 6.775M--

--2024/Q4-- / 10.494M--

--2024/Q310.524M / 10.358M--

--2024/Q29.477M / 10.635M--

--2024/Q111.684M / 9.135M--

Unlock Free Earnings Estimates

Open Account

EyePoint Pharmaceuticals Earnings Reports

EyePoint Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 7 16:08 ET

EyePoint Pharmaceuticals | 8-K: EyePoint Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Corporate Developments

Nov 7 07:08 ET

EyePoint Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

Aug 8 16:13 ET

EyePoint Pharmaceuticals | 8-K: EyePoint Pharmaceuticals Reports Second Quarter 2024 Financial Results and Highlights Recent Corporate Developments

Aug 7 07:01 ET

Analyst Rating

Updated: Nov 30, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall